AR and Alzheimer disease: To test this possibility, we analyzed the AR chromatin immunoprecipitation (ChIP)-seq data in AD LNCaP cells (GEO#: GSM699631) and observed multiple potential AR-binding sites (ABS) or peaks across the ~182 kb LRIG1 genomic region, some of which harbored AR and/or FOXA motifs (Fig. 7c, d; Supplementary Fig. 14g, h).